BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24055172)

  • 1. Spry1 and Spry2 are necessary for eyelid closure.
    Kuracha MR; Siefker E; Licht JD; Govindarajan V
    Dev Biol; 2013 Nov; 383(2):227-38. PubMed ID: 24055172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spry1 and Spry2 are necessary for lens vesicle separation and corneal differentiation.
    Kuracha MR; Burgess D; Siefker E; Cooper JT; Licht JD; Robinson ML; Govindarajan V
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6887-97. PubMed ID: 21743007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF-regulated BMP signaling is required for eyelid closure and to specify conjunctival epithelial cell fate.
    Huang J; Dattilo LK; Rajagopal R; Liu Y; Kaartinen V; Mishina Y; Deng CX; Umans L; Zwijsen A; Roberts AB; Beebe DC
    Development; 2009 May; 136(10):1741-50. PubMed ID: 19369394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative and independent functions of FGF and Wnt signaling during early inner ear development.
    Wright KD; Mahoney Rogers AA; Zhang J; Shim K
    BMC Dev Biol; 2015 Oct; 15():33. PubMed ID: 26443994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spry1 and Spry4 differentially regulate human aortic smooth muscle cell phenotype via Akt/FoxO/myocardin signaling.
    Yang X; Gong Y; Tang Y; Li H; He Q; Gower L; Liaw L; Friesel RE
    PLoS One; 2013; 8(3):e58746. PubMed ID: 23554919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated activity of Spry1 and Spry2 is required for normal development of the external genitalia.
    Ching ST; Cunha GR; Baskin LS; Basson MA; Klein OD
    Dev Biol; 2014 Feb; 386(1):1-11. PubMed ID: 24361260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial-mesenchymal transition.
    Zhang Q; Wei T; Shim K; Wright K; Xu K; Palka-Hamblin HL; Jurkevich A; Khare S
    Oncogene; 2016 Jun; 35(24):3151-62. PubMed ID: 26434583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cosuppression of Sprouty and Sprouty-related negative regulators of FGF signalling in prostate cancer: a working hypothesis.
    Assinder SJ; Beniamen D; Lovicu FJ
    Biomed Res Int; 2015; 2015():827462. PubMed ID: 26075267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses.
    Sharma B; Joshi S; Sassano A; Majchrzak B; Kaur S; Aggarwal P; Nabet B; Bulic M; Stein BL; McMahon B; Baker DP; Fukunaga R; Altman JK; Licht JD; Fish EN; Platanias LC
    J Biol Chem; 2012 Dec; 287(50):42352-60. PubMed ID: 23074222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sprouty genes prevent excessive FGF signalling in multiple cell types throughout development of the cerebellum.
    Yu T; Yaguchi Y; Echevarria D; Martinez S; Basson MA
    Development; 2011 Jul; 138(14):2957-68. PubMed ID: 21693512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sprouty is a negative regulator of transforming growth factor β-induced epithelial-to-mesenchymal transition and cataract.
    Shin EH; Basson MA; Robinson ML; McAvoy JW; Lovicu FJ
    Mol Med; 2012 Jul; 18(1):861-73. PubMed ID: 22517312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPRY1 regulates mammary epithelial morphogenesis by modulating EGFR-dependent stromal paracrine signaling and ECM remodeling.
    Koledova Z; Zhang X; Streuli C; Clarke RB; Klein OD; Werb Z; Lu P
    Proc Natl Acad Sci U S A; 2016 Sep; 113(39):E5731-40. PubMed ID: 27621461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2.
    Nadeau RJ; Toher JL; Yang X; Kovalenko D; Friesel R
    J Cell Biochem; 2007 Jan; 100(1):151-60. PubMed ID: 16888801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sprouty proteins inhibit receptor-mediated activation of phosphatidylinositol-specific phospholipase C.
    Akbulut S; Reddi AL; Aggarwal P; Ambardekar C; Canciani B; Kim MK; Hix L; Vilimas T; Mason J; Basson MA; Lovatt M; Powell J; Collins S; Quatela S; Phillips M; Licht JD
    Mol Biol Cell; 2010 Oct; 21(19):3487-96. PubMed ID: 20719962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tesk1 interacts with Spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling.
    Chandramouli S; Yu CY; Yusoff P; Lao DH; Leong HF; Mizuno K; Guy GR
    J Biol Chem; 2008 Jan; 283(3):1679-1691. PubMed ID: 17974561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dosage-dependent role for Spry2 in growth and patterning during palate development.
    Welsh IC; Hagge-Greenberg A; O'Brien TP
    Mech Dev; 2007; 124(9-10):746-61. PubMed ID: 17693063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spry1 is expressed in hemangioblasts and negatively regulates primitive hematopoiesis and endothelial cell function.
    Yang X; Gong Y; Friesel R
    PLoS One; 2011 Apr; 6(4):e18374. PubMed ID: 21483770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Spry1 in chondrocytes causes attenuated FGFR ubiquitination and sustained ERK activation resulting in chondrodysplasia.
    Yang X; Harkins LK; Zubanova O; Harrington A; Kovalenko D; Nadeau RJ; Chen PY; Toher JL; Lindner V; Liaw L; Friesel R
    Dev Biol; 2008 Sep; 321(1):64-76. PubMed ID: 18582454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wakayama Symposium: Epithelial-mesenchymal interactions in eyelid development.
    Ohuchi H
    Ocul Surf; 2012 Oct; 10(4):212-6. PubMed ID: 23084141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.
    Hanafusa H; Torii S; Yasunaga T; Nishida E
    Nat Cell Biol; 2002 Nov; 4(11):850-8. PubMed ID: 12402043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.